Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients - PWR 12.02.2022
powernephron
Published on Dec 13, 2022
Dr. Karen Shalansky, Dr. Kevin Kwok, Dr. Hilary Wu present, "Safety of IV Iron Products and Review of Ferric Derisomaltose in CKD Patients."
Category
- Your Subscription
powernephron -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
35:15
Management of Hyperkalemia in Patients With Hemodialysis-Dependent CKD
126 views 1465 days ago -
25:08
HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
100 views 1260 days ago -
24:13
Gestational and Chronic Hypertension - CRASH! Medical Review Series
61 views 1008 days ago -
47:17
Renin angiotensin system blockade in COVID-19: A tumultuous year in review
70 views 1441 days ago -
52:24
New Insights into the Diagnosis and Treatment of AKI in Patients with ADHF
107 views 1441 days ago -
30:35
Christopher Blosser, MD - Cancer in Patients with Kidney Disease
63 views 1263 days ago